Sat, Dec 20, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Cerulli: European managers brush off emerging market debt woes

Wednesday, July 24, 2013
Opalesque Industry Update - With central bank statements dictating fund flows, traditionally risky strategies are laid bare. However, manager conviction in emerging market debt (EMD) strategies is not lost, according to the July edition of The Cerulli Edge - European Monthly Product Trends.

"The recent pummeling that EMD received has undoubtedly shaken some investors and the next few months could prove difficult for EMD managers," commented Barbara Wall, director at Cerulli Associates. "A clear philosophy is critical. Managers who ignore so-called hot money movements are those that will be selling in five years' time."

There is plenty of evidence to demonstrate sustained interest in EMD. At a Cerulli asset manager roundtable event 14% of the attendees said that EMD was likely to win the most mandates from sovereign wealth funds over the next 12 months. The majority (64%) said the same of alternatives, while 21% thought emerging market equities was a likely contender.

Yoon Ng, a Cerulli associate director, noted that of the top-10 funds by 2013 sales in EMD, four have associated their brand with the asset class. "Several significant soft closures from the likes of Aberdeen, First State, and Franklin Templeton have left a gap in the market that other groups are looking to fill," she added.

Other Findings:

• European providers have delisted a record 231 exchange-traded products (ETPs) in the first half of the year, with many issuers justifying the move as allowing them to better focus on liquidity. The growth of the ETP market over the past few years has resulted in too many similar or very small products; fund rationalization is the next logical step.
• Institutional investors and discretionary buyers have an appetite for new investment strategies, while looking to diversify their manager base. Cerulli believes that Swiss private banks and funds of funds in particular are going out of their way to find innovative strategies for their clients.
• Cross-border U.K.-domiciled funds garnered €1.5 billion (US$1.96 billion) of NNF in May, the second-largest figure after Luxembourg-domiciled funds. U.K. YTD sales amounted to €8.3 billion, making it the third top-selling market after Luxembourg and Ireland. To cement its position as a cross-border center, Ireland is targeting Asian managers to grow its non-European UCITS marketshare.

press release

www.cerulli.com

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und